Literature DB >> 21631294

GATA4 specific nonsynonymous single-nucleotide polymorphisms in congenital heart disease patients of Mysore, India.

Sosalagere M Dinesh1, Kusuma Lingaiah, Mysore R Savitha, Balasundaram Krishnamurthy, Doddaiah Narayanappa, Nallur B Ramachandra.   

Abstract

Congenital heart disease (CHD) is the most common type of birth defect, affecting 1% of all live births. The recent exponential increase in the knowledge of medical genetics has revolutionized the understanding of CHDs during the past few decades. GATA4, a transcription factor, is involved in heart development. There are many contradictory reports on involvement of single-nucleotide polymorphisms (SNPs) of GATA4 in the manifestation of CHD. In view of this, an attempt has been made to analyze the known SNPs of GATA4 in Mysore patients with CHD. Of the 308 CHD patients recruited, 100 were screened for SNPs of GATA4 by MassARRAY, which identified 11 SNPs, of which 6 were found in both CHD cases and controls. The other 5 SNPs, c.278G>C (G93A), c.1207C>A (L403M), c.1232C>T (A411V), c.1295T>C (L432S), and c.1180C>G (P394A), were found only in CHD patients. Secondary structure analysis revealed that mutant proteins with the SNPs G93A, L403M, and L432S showed structural changes in their helix, sheet, and turn. Thus, these findings suggest the involvement of specific SNPs of GATA4 in the manifestation of CHD, reported for the first time in an Indian scenario. However, screening for a larger number of CHD patients would help us to establish genotype-phenotype correlation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21631294     DOI: 10.1089/gtmb.2010.0278

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  7 in total

Review 1.  Transcription factor pathways and congenital heart disease.

Authors:  David J McCulley; Brian L Black
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

2.  Absence of GATA4 Mutations in Moroccan Patients with Atrial Septal Defect (ASD) Provides Further Evidence of Limited Involvement of GATA4 in Major Congenital Heart Defects.

Authors:  Ihssane El Bouchikhi; Laila Bouguenouch; Fatima Zohra Moufid; Khadija Belhassan; Imane Samri; Amal Chaouti; Mohammed Iraqui Houssaïni; Samir Atmani; Karim Ouldim
Journal:  Eurasian J Med       Date:  2020-10

3.  c.620C>T mutation in GATA4 is associated with congenital heart disease in South India.

Authors:  Saidulu Mattapally; Sheikh Nizamuddin; Kona Samba Murthy; Kumarasamy Thangaraj; Sanjay K Banerjee
Journal:  BMC Med Genet       Date:  2015-02-18       Impact factor: 2.103

4.  GATA4 molecular screening and assessment of environmental risk factors in a Moroccan cohort with tetralogy of Fallot.

Authors:  Ihssane El Bouchikhi; Khadija Belhassan; Fatima Zohra Moufid; Mohammed Iraqui Houssaini; Laila Bouguenouch; Imane Samri; Mohamed Bouhrim; Karim Ouldim; Samir Atmani
Journal:  Afr Health Sci       Date:  2018-12       Impact factor: 0.927

5.  GATA4 screening in Iranian patients of various ethnicities affected with congenital heart disease: Co-occurrence of a novel de novo translocation (5;7) and a likely pathogenic heterozygous GATA4 mutation in a family with autosomal dominant congenital heart disease.

Authors:  Samira Kalayinia; Majid Maleki; Hassan Rokni-Zadeh; Majid Changi-Ashtiani; Hassan Ahangar; Alireza Biglari; Tina Shahani; Nejat Mahdieh
Journal:  J Clin Lab Anal       Date:  2019-05-22       Impact factor: 2.352

6.  Effect of Structural Changes in Proteins Derived from GATA4 Nonsynonymous Single Nucleotide Polymorphisms in Congenital Heart Disease.

Authors:  D S Manjegowda; P Karunakar; N B Ramachandra
Journal:  Indian J Pharm Sci       Date:  2015 Nov-Dec       Impact factor: 0.975

7.  In silico analysis of GATA4 variants demonstrates main contribution to congenital heart disease.

Authors:  Shiva Abbasi; Neda Mohsen-Pour; Niloofar Naderi; Shahin Rahimi; Majid Maleki; Samira Kalayinia
Journal:  J Cardiovasc Thorac Res       Date:  2021-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.